Logo image of MYSE

MYSEUM INC (MYSE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MYSE - US23816M2061 - Common Stock

1.77 USD
+0.09 (+5.36%)
Last: 11/21/2025, 8:00:01 PM
1.74 USD
-0.03 (-1.69%)
Pre-Market: 11/24/2025, 8:00:00 AM
Fundamental Rating

2

Taking everything into account, MYSE scores 2 out of 10 in our fundamental rating. MYSE was compared to 280 industry peers in the Software industry. No worries on liquidiy or solvency for MYSE as it has an excellent financial health rating, but there are worries on the profitability. MYSE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MYSE had negative earnings in the past year.
In the past year MYSE has reported a negative cash flow from operations.
In the past 5 years MYSE always reported negative net income.
In the past 5 years MYSE always reported negative operating cash flow.
MYSE Yearly Net Income VS EBIT VS OCF VS FCFMYSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of -64.54%, MYSE is doing worse than 87.14% of the companies in the same industry.
The Return On Equity of MYSE (-52.17%) is worse than 69.29% of its industry peers.
Industry RankSector Rank
ROA -64.54%
ROE -52.17%
ROIC N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
MYSE Yearly ROA, ROE, ROICMYSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

MYSE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MYSE Yearly Profit, Operating, Gross MarginsMYSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -200K -400K -600K -800K -1M

More info and screens

7

2. Health

2.1 Basic Checks

MYSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
MYSE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, MYSE has more shares outstanding
There is no outstanding debt for MYSE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MYSE Yearly Shares OutstandingMYSE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
MYSE Yearly Total Debt VS Total AssetsMYSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

MYSE has an Altman-Z score of -14.48. This is a bad value and indicates that MYSE is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MYSE (-14.48) is worse than 91.07% of its industry peers.
MYSE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.48
ROIC/WACCN/A
WACC10.99%
MYSE Yearly LT Debt VS Equity VS FCFMYSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

MYSE has a Current Ratio of 8.98. This indicates that MYSE is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 8.98, MYSE belongs to the best of the industry, outperforming 94.64% of the companies in the same industry.
A Quick Ratio of 8.98 indicates that MYSE has no problem at all paying its short term obligations.
MYSE has a Quick ratio of 8.98. This is amongst the best in the industry. MYSE outperforms 94.64% of its industry peers.
Industry RankSector Rank
Current Ratio 8.98
Quick Ratio 8.98
MYSE Yearly Current Assets VS Current LiabilitesMYSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.58% over the past year.
The Revenue for MYSE has decreased by -33.33% in the past year. This is quite bad
EPS 1Y (TTM)47.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.51%
Revenue 1Y (TTM)-33.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYSE Yearly Revenue VS EstimatesMYSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10K 20K 30K 40K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYSE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSE Price Earnings VS Forward Price EarningsMYSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSE Per share dataMYSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MYSE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYSEUM INC

NASDAQ:MYSE (11/21/2025, 8:00:01 PM)

Premarket: 1.74 -0.03 (-1.69%)

1.77

+0.09 (+5.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners5.05%
Inst Owner ChangeN/A
Ins Owners4.49%
Ins Owner Change9.31%
Market Cap7.54M
Revenue(TTM)400
Net Income(TTM)-4.81M
AnalystsN/A
Price TargetN/A
Short Float %4.78%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 18850.5
P/FCF N/A
P/OCF N/A
P/B 0.82
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)-1.35
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.09
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS0
BVpS2.16
TBVpS1.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -64.54%
ROE -52.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.98
Quick Ratio 8.98
Altman-Z -14.48
F-Score3
WACC10.99%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.09%
OCF growth 3YN/A
OCF growth 5YN/A

MYSEUM INC / MYSE FAQ

Can you provide the ChartMill fundamental rating for MYSEUM INC?

ChartMill assigns a fundamental rating of 2 / 10 to MYSE.


Can you provide the valuation status for MYSEUM INC?

ChartMill assigns a valuation rating of 0 / 10 to MYSEUM INC (MYSE). This can be considered as Overvalued.


Can you provide the profitability details for MYSEUM INC?

MYSEUM INC (MYSE) has a profitability rating of 0 / 10.